Reluctance to adopt AI at scale boils to fear of change; while technical factors include inadequate training, client ...

Experts discuss the crucial role of government in enhancing India's participation in clinical trials at BioAsia 2025 panel.

Hyderabad: The Contract Research, Development, and Manufacturing Organisation (CRDMO) sector in India is at an inflection ...

India currently holds a 2-3 per cent share of the USD 140-145 billion global CRDMO market but has the potential to become a ...

Nesh, the Sales AI platform for chemicals, materials, and advanced manufacturing, today launched new generative AI workflows ...

How is AI Shaping India’s Digital Future? To explore this pivotal question, Lenovo, ETCIO, and Times Techies have launched ...

Working toward more effective tuberculosis (TB) vaccines, researchers at Weill Cornell Medicine have developed two strains of ...

India's CRDMO sector is poised for significant growth, with potential to reach USD 25 billion by 2035, driven by de-risking ...

Innovative research at Weill Cornell Medicine introduces engineered mycobacteria strains with 'kill switches' for safer TB ...

Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of ...

The fashion industry is at a pivotal moment, facing mounting environmental and social challenges that demand urgent and ...